Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02734 |
| Species: | Mus musculus |
| Position : | chr10:24212605-24214888 |
| Year: | 2018 |
| Title: | Multiple enhancer regions govern the transcription of CCN2 during embryonic development. |
| Genome Build: | mm9 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 29256171 |
| Tissue: | dermis |
| Tissue Ontology ID: | UBERON:0002067 |
| Cell Source: | E15.5 transgenic mouse embryo |
| Cell Type: | dermal microvascular endothelial cell |
| Cell Ontology ID: | CL:0011030 |
| Experiment Type: | In vivo enhancer activity assay; Enhancer activity assay |
| High Throughput Method: | ENCODE H3K4me1 ChIP-seq; H3K27ac ChIP-seq; DNase-seq data integration |
| Low Throughput Method: | Hsp68-LacZ transgenic mouse reporter assay; whole-mount X-gal staining; histological analysis; Transgenic enhancer reporter assay |
| Target gene : | Ccn2 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02731 | chr10:24214247-24216247 | dermis | endothelial cell | NA |